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Abstract 
This article discusses theory behind the most important methods and recent successful applications of 
halogen-directed tinosporide, ligand-based methods use only ligand information for predicting activity 
depending on its similarity/dissimilarity to previously known active ligands. We review widely used 
ligand-based methods such as ligand-based pharmacophores, molecular descriptors, and quantitative 
structure-activity relationships. In addition, important tools such as target/ligand data bases, homology 
modeling, ligand ADMET etc., and necessary for successful implementation of various computer-aided 
drug discovery/design methods in best analogue of tinosporides discovery are discussed. Finally, 
computational methods for toxicity prediction and optimization for favorable physiologic properties are 
discussed with successful lead for tinosporides from literature. The therapeutic potential of tinosporide 
has been studied extensively and the active compounds of tinosporide are shown to be involved in 
modulating multiple physiological responses. Moreover this article will review the structure of series of 
halogen-directed tinosporides before illustration on how the molecules exert their functions via 
interactions with various signal transducer and activator proteins of transcription which were designed by 
homology modeling. Strategies for CADD vary depending on the extent of structural and other 
information available regarding the target (enzyme/receptor) and the ligands. The process by which a new 
tinosporide product is brought to market stage is referred to by a number of names most commonly as the 
development chain and consists of a number of distinct stages.  
Keywords: CADD; ADMET; Molecular Modeling; Tinosporide. 
 
1. Introduction 
As the nature is an important library for various novel compounds because of enormous chemical 
diversity present in millions of species of plants, animals, marine organisms, and microorganisms. 
Tinosporide is a bio-active molecule isolated from Tinospora cordifolia that serves as a potential source 
of anti-cancer and to control high cholesterol and to enhance the activity of the body's immune system 
[1]. To determine the anti-cancer activity of tinosporide and its halogenated derivatives, computational 
tools have been used to investigate the best ligand and optimized receptors protein as the best choice for 
the future scientists. Tinospora cordifolia was selected as a potential source. The position of –OH group in 
the chemical structure of tinosporide was carbon-10 that was changed to carbon- 8 position as main 
compound and also the –OH group in carbon-8 was modified with –F, -Cl, -Br, -I and –CF3 for the 
identification of hit -to -lead.  
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2. Computational Procedure 
2.1. Materials and Methods  
The crystal structures of proteins 5HFA, 5HF5, 5HF6, 5HF8, 5HF9 of acetylcholinesterase group and 
5LKR, 5DYT, 5DYW, 5DYY, 4XII of butyrylcholinesterase group of homo sapience have been collected 
from RCSB PDB protein databank [2]. All the proteins were optimized for the experimentation using 
protein preparation module of Schrodinger’s Maestro modeling suit [3]. Hydrogen atoms were added 
followed by energy minimization and optimization by Chem3DPro12.0 program. The docking was done 
by PyRx and selected non-covalent interactions among ligands and proteins were obtained by Discovery 
Studio 2016. MedChem Designer, admetSAR@LMMD, PreADMET was used for ADMET analysis of 
the identified compound and PreADMET was also used for the toxicity analysis of the identified 
compound. WebMO Login. Version: 18.0.002e was used for HOMO-LUMO analysis of the identified 
compound.  
2.2. Protein Preparation                                                                                                                                                                                       
Before docking, heteroatoms, lipids and water molecules were withdrawn from the crystal structure 
using PyMOl (version 1.7.4.5) [4]. Geometry and energy minimization of the crystal structure were 
carried out with Swiss-PDB Viewer (version 4.1.0) employing GROMOS96 force field 12. Finally the 
ligand and protein structures were saved as PDB files. Proteins were selected for tinosporide by Swiss 
Target Predictor.  
2.3. Ligands Optimization  
All predictions were done by using Gaussian view 09 and Chem3D Pro12.0 program packages [5]. 
Initial three-dimensional geometry of chair forms of tinosporide was retrieved. The main drug was 
modified with F, Cl, Br, I and –CF3 functional groups. These structures were fully optimized by density 
functional theory. Midix basis set was employed for –Cl, –Br and –I substituted ligands, while 6-311G (d, 
p) basis set was used for the parent drug and the –F and –CF3 modified derivatives in Figure 1. 
 
D-Tinosporide_chair 
 
D-F_chair 
 
D-Cl_chair 
 
D-Br_chair 
 
D-I_chair 
 
D-CF3 _chair 
Figure 1. Preparation of derivatives. 
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Figure 2. Identification of ligands by Chem NMR H-1 estimation. 
 
3. Results and Discussion  
3.1. Admet Analysis of the Identified Compounds 
Ligand screening was based on hierarchal screening approach in docking. High through virtual 
screening (HTVS) and MedChem Designer, admetSAR@LMMD, PreADMET softwares were used for 
absorption, distribution, metabolism, and excreation and toxicity analysis of the halogen-modified 
derivatives. According to MedChem Designer, in generally, lipophilicity is the logarithm value of the 
partition coefficient P (logP) between octanol and water (buffer), which explains the partition of the 
unionized (neutral) form of the compound, whereas logD describes the total partition of both the ionized 
and the unionized forms of the compound [6]. Compounds have logp value more than 5 indicating their 
lipophilic proprieties, whereas compounds D-F, D-Cl, D-Br and its analogues D-I and D-CF3 showed low 
logP values less than 5 expressing their hydrophilic nature. MlogP (Moriguchi octanol-water partition 
Journal of Natural Sciences Research                                                                                                                                                      www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.8, Special Issue for ICNST 2018 
 
 60 
coefficient) is well known and is traditionally used in QSAR model structure analysis. It describes the 
lipophilicity of a compound, which indicates the penetration of the compound from aqueous solutions to 
lipid-rich zones. Moriguchi's logP (MLogP) of greater than 4.15 suggests that the compound would be 
poorly absorbed [7]. The calculated MLogP of compounds D-F, D-Cl, D-Br and its analogues D-I and D-
CF3 showed calculated MLogP value significantly less than 4.15, suggesting that these compounds would 
be easily absorbed. (Table 1-3). 
 
Table 1. Medchem designer admet values. 
ID D D-F D-Cl D-Br D-CF3 D-I 
MlogP 0.99 1.56 1.45 1.67 1.89 1.87 
S+logP 1.27 2.46 2.05 2.57 2.71 2.86 
S+logD 1.27 2.46 2.05 2.57 2.71 2.86 
MWt 374.39 392.83 376.38 437.29 426.39 484.29 
 
Table 2. AadmetSAR@LMMD- ADMET values. 
AdmetSAR@LMMD was used for the prediction of following parameters of the compound. 
Parameters     D   D-F    D-Cl  D-Br    D-I D-CF3 
Blood Brain Barrier 0.888 0.938  0.930 0.927 0.914 0.941 
Human Intestinal 
Absorption 
0.969 0.996  0.996 0.994 0.979 1.000 
Caco-2 Permeability 0.571 0.500  0.500 0.509 0.509 0.532 
P-glycoprotein Inhibitor 0.723 0.500  0.550 0.692 0.570 0.857  
Human Ether a-go-go-
Related (hERG) Gene 
Inhibition 
0.991 0.991  0.984 0.990 0.987 0.983 
Acute Oral Toxicity 
 
0.349 0.494  0.463 0.4978 0.497 0.404 
Rat Acute Toxicity, 
LD50 (mol/kg) 
3.239 2.692  2.651 2.682 2.649 2.920 
Aqueous Solubility -4.097 -4.354 -4.545 -4.470 -4.511 -5.001 
 
Table 3. PreADMET-ADMET Values. 
PreADMET was used for the ADMET analysis of the following identified compound. 
Parameters     D D-F D-Cl D-Br D-I D-CF3 
Buffer_solubility_mg/L  79580.6 79580.6 57511.4 3330.93 926.62 7081.01 
Plasma_Protein_Binding 89.91 89.91 82.43 99.61 100.00 92.08 
Pure_water_solubility_mg 7.78 7.78 30.00 4.80 1.61 6.44 
Skin_Permeability -4.32 -4.32 -4.28 -4.33 -4.33 -3.53 
 
3.2. Toxicity Analysis of Compounds 
PreADMET was also used for the toxicity analysis of the following identified compound. Toxicity of 
all the compounds were predicted by PreADMET suggesting that all the compounds having toxicity less 
than 1.0 given in Table 4. 
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Table 4. Toxicity analysis. 
ID D D-F D-Cl D-Br D-I D-CF3 
algae_at 0.115 0.105 0.115 0.063 0.042 0.064 
daphnia_at 0.420 0.295 0.420 0.148 0.047 0.206 
medaka_at 0.259 0.127 0.259 0.034 0.005 0.063 
minnow_at 0.241 0.083 0.241 0.023 0.003 0.031 
                                                                                                                                                                                                                                        
3.3. Homo-Lumo, Gap, Hardness and Softness Analysis 
Hardness (η) and softness (S) of all drugs were also calculated from the energies of frontier HOMOs 
(highest occupied molecular orbitals) and LUMOs (lowest unoccupied molecular orbitals). Hardness (η) 
and softness (S) of the drugs calculated according to the following equation (Pearson 1986, 1995) [8], [9]- 
 
 
 
                 
D-CF3 tinosporide showed small gap value 1.891, hardness 0.945 that was very lower and softness 
value 1.057 that was good for absorption in Table 5. So, D-CF3 tinosporide was the best among the 
derivatives. 
Table 5. HOMO-LUMO, Gap, Hardness and Softness analysis.             
Molecules 
 ε
HOMO 
 
LUMO Gap        Hardness S(Softness)     
D_Chair -7.871 -2.31 5.561        2.780 0.3596 
D-F_Chair -7.718 -1.226 6.492        3.246 0.308 
D-Cl-Chair -7.919 -2.305 5.614        2.807 0.3562 
D-Br_Chair -7.839 -0.746 7.093        3.546 0.5639 
D-I_Chair -6.641 -1.618 5.023        2.511 0.3981 
D-CF3_Chair -4.222 -2.331 1.891        0.945 1.0576 
 
3.4. Free energy of binding values (Kcalmol
−1
) for ligand – Achetylcholinesterase (AChE) (at chair 
form) systems obtained from docking 
The binding affinity of D-F tinosporide showed the value -8.9 for acetylcholinesterase (5HF9). So, D-
F -5HF9 showed the lowest binding energy in Table 7. 
Table 6. Free energy of binding values (Kcalmol
−1
) for ligand – Achetylcholinesterase (AChE)  
Protein D (chair) D-F (chair) D-Cl (chair) D-Br (chair) D-I(chair) D-CF3  (chair) 
HFA -7.9 -8.4    -8.4    -7.9 -7.8 -8.5 
5HF5 -8.1 -8.0 -8.1 -8.0 -8.1 -8.2 
5HF6 -8.2 -8.2    -8.2    -8.2 -8.1 -8.5 
5HF8 -8.1 -8.3   -8.1   -8.0 -7.8 -8.4 
5HF9 -8.9 -8.9 -8.7 -8.3 -7.8 -8.8 
 
 
 
2
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3.5. Free Energy of Binding Values (Kcalmol
−1
) for Ligand – Butyrylcholinesterase (At Chair 
Form) Systems Obtained From Docking 
The binding affinity of D-CF3 tinosporide showed the value -10.1 for butyrylcholinesterase (5DYW) 
in comparison with the main drug for butyrylcholinesterase showed the value -9.5. So, D-CF3 -5DYW 
showed the lowest binding energy in Table 7. 
Table 7.  Free energy of binding values (Kcalmol
−1
) for ligand – Butyrylcholinesterase.  
Protein   D (chair)  D-F 
(chair) 
 D-Cl 
(chair) 
 D-Br 
(chair) 
  D-I 
(chair) 
 D-CF3  
(chair) 
5LKR -9.1 -9.1  -9.4 -9.0 -8.7 -10.0 
5DYT  -8.9 -9.0  -8.7 -9.1 -9.0 -9.7 
5DYW -9.5 -9.5     -8.6    -9.8 -9.7 -10.1 
5DYY -8.9 -8.9    -8.6   -9.0 -8.8 -9.5 
4XII -8.9 -9.5  -8.7 -9.0 -9.0 -9.4 
 
3.6. Binding Site and Docking 
The active binding pocket of achetylcholinesterase and butyrylcholinesterase were predicted by 
CASTp. The binding site residues predicted by CASTP for achetylcholinesterase (D-5HF9, D-F-5HF9, 
D-Cl-5HF9, D-CF3-5HF9) and butyrylcholinesterase (D-CF3-5LKR, D-CF3-5DYW) were used for grid 
generation. The docked pose of lowest binding free energy conformer with the respective protein was 
analyzed using PyMOL Molecular Graphics System (version 1.7.4) [10]. Accelrys Discovery Studio 2016 
in Figure 3. 
  
                                                       
                                    D-5HF9  
                                                                                                                             
 
                                                                      
 
D-F-5HF9 
 
D-CF3-5LKR 
 
D-CF3  -5DYW 
Figure 3. Binding site ligands-proteins. 
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3.7. Selected Non-Covalent Interactions among Chair Ligands D, D-Cf3 and Butyrylcholinesterase 
(5dyw) Obtained by Discovery Studio 
Selected non-covalent interactions among chair ligands and proteins were given in Table 8-9. 
 
Table 8. Selected non-covalent interactions among chair ligands D, D-F and Achetylcholinesterase 
(5HF9) obtained via flexible docking. 
 
Table 9. Selected non-covalent interactions among chair ligands D-CF3 and Butyrylcholinesterase (5lkr, 
5dyw) obtained via flexible docking. 
Systems Contacts Bond 
distances (Å) 
Systems Contacts Bond 
distances (Å) 
D-CF3-
5LKR 
F…N-H(Asp 375) 2.655 D-CF3 -
5DYW 
O…H-H (Arg381) 2.556 
 O…H-H(Arg515) 2.517  O…H-H (Arg515) 2.403 
 O…C (Asn384) 3.239  O…C (Asn384) 3.086 
 Pi…σ (Val377) 3.778  Pi…Cation (Arg381) 4.430 
 Alkyl (Ala388) 5.459  Alkyl (Val377) 4.874 
 Pi-Alkyl (Arg381) 4.405  Pi-Alkyl (Val377) 3.958 
 
4. Conclusion 
Our study confirmed that the binding affinity of D-CF3 tinosporide showed the value -10.1 for 
butyrylcholinesterase 5DYW) in comparison with the main drug for butyrylcholinesterase and the binding 
affinity of D, D-F_tinosporide showed the value -8.9 for acetylcholinesterase (5HF9) in comparison with 
D-CF3 drug for acetylcholinesterase. So the cholinesterase proteins (5LKR, 5DYW) of 
butyrylcholinesterase and acetylcholinesterase protein (5HF9) are the best proteins. From all the data we 
have analyzed, claimed that the D, D-F (tinosporide) for acetylcholinesterase (5HF9) and D-CF3 
(tinosporide) for butyrylcholiesterase (5LKR, 5DYW) will be the best conformer and will be the best 
target as anti-cancer signal transducer protein for the future researchers.        
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Systems Contacts Bond 
distances(Å) 
Systems Contacts Bond 
distances (Å) 
D-5HF9 N…H-E (Gln413) 2.503 D-F-5HF9 O…H-E (Gln413) 2.477 
 O…C (Asn533) 3.343  O…C (Asn533) 3.317 
 F...O (His405) 3.278  F…O (Asn533) 3.446 
 Alkyl (Pro235) 5.076  Alkyl (Pro235) 5.037 
 Pi…Alkyl (His405) 4.362  Pi…Alkyl (His405) 4.386 
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